Omzo vs Telos Rx: Compounded semaglutide, pricing, clinician review
Quick verdict: Omzo and Telos Rx both offer clinician-reviewed access to compounded semaglutide and tirzepatide, but they differ most on starting price, how medication options are offered, and certain payment terms. Omzo focuses on personalized clinician-guided plans with compounded options and branded prescription referrals; Telos Rx emphasizes month-to-month compounded pricing as low as $99 per month for semaglutide if a licensed provider approves you.
Explore Omzo clinician-guided plans
Direct comparison: Omzo vs Telos Rx on the essentials
This comparison uses only supplied facts to contrast Omzo and Telos Rx across the most distinctive differences: pricing structure, medication sourcing and regulatory notes, clinician review and prescribing process, and payment or cancellation terms where supplied. The primary keyword Omzo vs Telos Rx appears throughout to help you quickly find this comparison.
1) Pricing and payment model
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 as captured on the landing page. Telos Rx advertises semaglutide as low as $99 per month and tirzepatide as low as $139 per month, with statements like pay $0 if not approved and cancel anytime, no penalties. The providers therefore present different entry pricing and billing language in the captured materials: Omzo uses a starting price for its programs, while Telos Rx shows per-month pricing with an explicit cancel anytime claim in the captured content.
2) Medication options and dispensing approach
Both providers offer compounded semaglutide and tirzepatide in their captured descriptions. Omzo describes a Compounded Medication Program where medications are prepared and shipped by a state-licensed sterile compounding pharmacy, and notes these compounded drugs are not FDA-approved. Omzo also states providers may write prescriptions for branded, FDA-approved medications that the patient must fill at a pharmacy because Omzo does not sell or ship branded products. Telos Rx likewise notes compounded semaglutide and tirzepatide are prescription-only, prescribed after review by a US-licensed provider, and that compounded medications are not FDA-approved. Neither source supplies details outside these statements.
3) Clinician review, eligibility, and provider role
Both Omzo and Telos Rx emphasize clinician review. Omzo says clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make the final determination to prescribe. Telos Rx states treatment is available only when a licensed clinician determines it is medically appropriate and that a US-licensed provider decides which molecule is right for you. Both sources preserve that prescriptions are subject to clinician review and that individual eligibility is determined by providers.
4) Regulatory and outcome disclaimers
Each source includes a regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Omzo additionally records statements that results vary, weight loss is not guaranteed, and the information is for educational purposes and does not constitute medical advice. Telos Rx captures that individual results vary and are not guaranteed. Those qualifiers are part of the provided evidence and are preserved here.
5) Cancellation, renewal, and customer commitments
Telos Rx captured messaging that users can cancel anytime with no penalties and that prices depend on plan. Omzo captured messaging about pricing and shipping policy but did not provide the same explicit cancel-anytime language in the supplied content. Both sources caution that pricing, eligibility, pharmacy, state coverage, and renewal terms may change.
| Criteria | Omzo | Telos Rx |
|---|---|---|
| Starting price (captured) | $179 semaglutide; $279 tirzepatide | Semaglutide as low as $99/month; tirzepatide as low as $139/month |
| Medication type | Compounded semaglutide and tirzepatide; providers may write prescriptions for branded meds that Omzo does not sell or ship | Compounded semaglutide and tirzepatide prescribed online after provider review |
| FDA status of compounded meds | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
| Clinician review | Licensed U.S. providers review and determine eligibility; third-party networks provide clinical services | Treatment prescribed only after review by a US-licensed provider |
| Payment and cancellation | Pricing listed as starting amounts; details on renewal and state availability may change | Advertises monthly pricing and cancel anytime, no penalties in captured content; price depends on plan |
How to choose between Omzo and Telos Rx
Choose based on the facts supplied: Omzo presents clinician-guided plans with starting program prices and the option for providers to write prescriptions for branded medications that you would fill separately. Telos Rx emphasizes lower monthly entry pricing in the captured content and explicit cancel-anytime language, with treatment available only after a licensed clinician approves you. Both warn that compounded medications are not FDA-approved and that eligibility and results vary.
Check Telos Rx clinician approval
Compare Omzo medication options
Final note: this comparison uses only the captured source facts. If you need details not supplied here – for example state availability, exact renewal terms, or full pricing schedules – those were not provided in the captured materials and you should confirm them directly with the provider.
Choose Omzo if you want clinician-guided plans that include compounded programs plus the option for providers to prescribe branded medications to fill separately. Choose Telos Rx if the captured month-to-month pricing as low as $99 per month for semaglutide and cancel-anytime language better matches your priorities. Omzo vs Telos Rx should be decided after you confirm eligibility, medication, total cost, renewal terms, and state availability with the provider.